Immune Tolerance Network   

A clinical research consortium sponsored by NIAID and JDRF

A research trial of Aralast in new-onset type 1 diabetes

Additional Type 1 Diabetes Studies.

RETAIN is no longer enrolling participants.

For information about the EXTEND study, another type 1 diabetes clinical trial being conducted by the Immune Tolerance Network, please visit